Natural History Study of Mitochondrial Myopathy
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Children's Hospital of Philadelphia
- Study ID
- NCT05250375
- Status
- Recruiting
Conditions
- Primary Mitochondrial Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - 100 Years
- Healthy Volunteers
- Accepted
Study Details
The goal of this observational study is to develop and validate tools to measure disease course in patients with primary mitochondrial myopathy (PMM). The main aims of this study are: * Development, validation, and optimization of objective outcome measures for mitochondrial myopathy * Defining the natural history of mitochondrial myopathy Researchers will compare data from patients with primary mitochondrial myopathy to healthy controls. Data from healthy controls will also help define normative data for future studies. Participants will perform clinical exams of muscle strength and endurance and will complete surveys.
Key Dates
- Start date
- Mar 24, 2017
- Status verified
- Sep 2025
- Primary completion
- Mar 24, 2030
- Completion
- Mar 24, 2030
Study Design
- Enrollment
- 1,300 participants (estimated)
Arms
- Arm: Primary Mitochondrial MyopathyPatients with a mitochondrial disorder established by confirmed genetic or biochemical mutation in mtDNA or nuclear DNA or is suitable for participation in the opinion of the investigator based on clinical presentation and exhibits myopathy (exercise intolerance, muscle strength, fatigue) relating to mitochondrial disease.
- Arm: Healthy ControlsMales or females age 0-100 years of age with no history of mitochondrial myopathy symptoms.
Primary Outcome Measure
Muscle Strength of MM-COAST [ Time Frame: through study completion, an average of 5 years ]
Central Contacts
- Katelynn Stanley, BS267 426 4961
- Jean Flickinger, PT267 426 4961
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 |
Find similar trials in Philadelphia, PA
Related Studies
- Efficacy of KL1333 in Adult Patients With Primary Mitochondrial DiseasePHASE2 · Recruiting · Abliva AB · Orange, California
- Neurometabolic Profile of Individuals With Primary Mitochondrial DiseaseRecruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania